| 7226940 |
Substituted heterocycles for the treatment of diabetes and other diseases |
Magnus Pfahl, Catherine Tachdjian, Hussien Al-Shamma, Andrea Fanjul, David Pleynet |
2007-06-05 |
$5,195,000 |
| 7196108 |
Bicyclic heterocycles for the treatment of diabetes and other diseases |
Magnus Pfahl, Catherine Tachdjian, Hussien Al-Shamma, Andrea Giachino, Karine Jakubowicz-Jaillardon +3 more |
2007-03-27 |
$3,702,000 |
| 7153875 |
Heterocyclic derivatives for the treatment of cancer and other proliferative diseases |
Magnus Pfahl, Catherine Tachdjian, Hussien Al-Shamma, Andrea Fanjul, David Pleynet +2 more |
2006-12-26 |
$6,353,000 |
| 7071218 |
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases |
Magnus Pfahl, Catherine Tachdjian, Hussien Al-Shamma, Mohamed Boudjelal, Andrea Fanjul +2 more |
2006-07-04 |
|
| 6974826 |
Imidazolidinedione derivatives for the treatment of diabetes and other diseases |
Magnus Pfahl, Catherine Tachdjian, Hussien Al-Shamma, Andrea Fanjul, David Pleynet |
2005-12-13 |
$7,350,000 |
| 6765013 |
Thiazolidinedione derivatives for the treatment of diabetes and other diseases |
Magnus Pfahl, Catherine Tachdjian, Hussien Al-Shamma, Andrea Fanjul, David Pleynet |
2004-07-20 |
$7,485,000 |
| 6656910 |
Serine protease inhibitors |
Albert Gyorkos |
2003-12-02 |
$82,000 |
| 6656911 |
Serine protease inhibitors |
Albert Gyorkos |
2003-12-02 |
$82,000 |
| 6608175 |
Serine protease inhibitors |
Albert Gyorkos |
2003-08-19 |
$170,000 |
| 6548638 |
Peptoid and nonpeptoid containing &agr;-keto oxadiazoles as serine protease inhibitors |
Albert Gyorkos, Kazuyuki Ohmoto, Kazuhito Kawabata |
2003-04-15 |
$155,000 |
| 6515003 |
Heterocyclic derivatives for the treatment of diabetes and other diseases |
Magnus Pfahl, Catherine Tachdjian, Hussien Al-Shamma, Andrea Fanjul, David Pleynet |
2003-02-04 |
$1,149,000 |
| 6255453 |
Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors |
Albert Gyorkos, Kazuyuki Ohmoto, Kazuhito Kawabata |
2001-07-03 |
$297,000 |
| 6159938 |
Serine protease inhibitors comprising .alpha.-keto heterocycles |
Albert Gyorkos, Axel Leimer, John C. Cheronis |
2000-12-12 |
$365,000 |
| 6150334 |
Serine protease inhibitors-tripeptoid analogs |
Albert Gyorkos |
2000-11-21 |
$343,000 |
| 6100238 |
Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors |
Albert Gyorkos |
2000-08-08 |
$239,000 |
| 6075120 |
Bradykinin antagonist |
John C. Cheronis, James K. Blodgett, Val S. Goodfellow, Manoj Vinayak Marathe, Eric T. Whalley |
2000-06-13 |
$272,000 |
| 6037325 |
Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
Albert Gyorkos |
2000-03-14 |
$254,000 |
| 6015791 |
Serine protease inhibitors-cycloheptane derivatives |
Albert Gyorkos |
2000-01-18 |
$123,000 |
| 6004933 |
Cysteine protease inhibitors |
Albert Gyorkos, John C. Cheronis, Val S. Goodfellow, Axel Leimer, John M. Young +1 more |
1999-12-21 |
$120,000 |
| 6001811 |
Serine protease inhibitors--N-substituted derivatives |
Albert Gyorkos |
1999-12-14 |
$42,000 |
| 6001814 |
Serine protease inhibitors |
Albert Gyorkos |
1999-12-14 |
$42,000 |
| 6001813 |
Val-pro containing .alpha.-keto oxadiazoles as serine protease inhibitors |
Albert Gyorkos |
1999-12-14 |
$42,000 |
| 5998379 |
Serine protease inhibitors-proline analogs |
Albert Gyorkos |
1999-12-07 |
$115,000 |
| 5891852 |
Serine protease inhibitors-cycloheptane derivatives |
Albert Gyorkos |
1999-04-06 |
$201,000 |
| 5874585 |
Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
Albert Gyorkos |
1999-02-23 |
$301,000 |